Molecular Partners AG American Depositary Shares
MOLN
Closed
$4.02
Closed
-(-)
At close
Get professional financial guidance
Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply
About
Molecular Partners AG engages in the provision of development of protein therapies for treatment of serious diseases like cancer and sight-threatening disorders. The firm has formed partnerships with leading pharmaceutical companies to advance DARPin therapeutics , and has compounds in various stages of clinical and preclinical development across multiple therapeutic areas.
Country
CH
CEO
Dr. Patrick Amstutz
IPO date
2014
Employees
149
ISIN
CH0256379097
Website
Key stats
Open
$3.95
Volume
2.35K
Market cap
$160.62M
Prev. close
$4.02
Impl / hst vl
-
Open interest
$0.00
$3.95
Day’s Range
$4.02
$3.66
52W Range
$5.36
Valuation
38
Valuation score
Overvalued
P/E
-
P/S
-
P/B
1.89
Current ratio
9.42
Debt / Equity
-0.89
ROE
-85.24%
Gross margin
-
Income growth
3.91%
FCF growth
26.13
Analysts estimates
Consensus rating
Buy
The average rating from top 5 analysts indicates that stock is expected to perform in line with the market
Str. Sell
Sell
Hold
Buy
Str. Buy
Avg. price target
$11.86
The top 6 analysts forecasts that 12-month price may increase by 194.90%, with a low of $6.29 and a high of $19.61
$6.29
Low
$11.86
Avg
$19.61
High
Current price
Earnings
Q1 ‘26 revenue
$0.00
Q1 ‘26 net income
-$16.29M
Revenue
Net income
Previous EPS
-$0.29
Estimate EPS
$0.00
Actual EPS
Estimate EPS
Explore the Healthcare sector
Get professional financial guidance
Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply